Blisseth Sy

Blisseth Sy has a strong background in business development and sales, with experience in the biotechnology and pharmaceutical industries. They most recently worked as the Director of Business Development at OmniAb, Inc. since January 2023. Prior to that, they were the Director of Business Development at AlivaMab Discovery Services from April 2021 to December 2022.

Blisseth also has experience in global business development and strategic partnerships. They served as the Associate Director of Business Development at Charles River Laboratories from January 2019 to February 2021. During their time there, they played a key role in driving global business development for a strategic partnership between Charles River Labs and Distributed Bio, which ultimately led to the acquisition of Distributed Bio. They exceeded a $16 million sales target and worked closely with 17 colleagues across the USA, EU, and Asia.

Before their role at Charles River Labs, Blisseth worked as an Emerging Biotech Account Manager at MilliporeSigma, a division of Merck KGaA, Darmstadt, Germany, from April 2017 to December 2018. They successfully identified and pursued sales opportunities with startup biologics drug discovery clients and achieved 150% of their business objectives. They utilized their technical background to understand customer needs and provided guidance for process optimization.

Prior to that, Blisseth held positions as a Senior Research Associate at Dynavax Technologies from January 2016 to February 2017, where they contributed to the research and development of vaccine adjuvants and immuno-oncology drugs. They also worked as an Associate Scientist at Bayer in the Process Development department from January 2015 to December 2015, specializing in protein purification process development and scale-up.

Blisseth started their career at Genentech as a Research Associate in the Antibody Drug Conjugation department from 2012 to 2014. Their work focused on the research and development of therapeutic antibodies for oncology targets.

They also gained experience in sales as an Inside Sales Account Manager at Bio-Rad from March 2011 to December 2011, where they managed and maintained relationships with clients in the life science industry.

Before entering the biotechnology and pharmaceutical industries, Blisseth worked in environmental conservation at various agencies from August 2009 to September 2010.

Overall, Blisseth Sy has a diverse range of experience in business development, sales, and research and development, with a focus on the biotechnology and pharmaceutical sectors.

Blisseth Sy has a Bachelor's degree in Molecular and Cell Biology, with an emphasis on Biochemistry, from the University of California, Berkeley. They also have a Master of Science (MS) degree in Biochemistry and Molecular Biology from the University of California, Davis. In addition to their formal education, Blisseth Sy has also completed coursework in Clinical Trials Design and Management at San Francisco State University in September 2007.